初次全膝关节置换中传统与高交联聚乙烯的翻修率比较:基于英格兰、威尔士和北爱尔兰国家关节登记数据
该回顾性分析基于2003至2014年国家关节登记中550,658例初次全膝关节置换,比较钴铬-传统聚乙烯与钴铬-高交联聚乙烯的翻修率。结果显示高交联聚乙烯无总体生存获益,无菌翻修率反而更高,常规使用可能缺乏性价比依据;但在年龄<60岁且BMI>35 kg/m²的特定高需求亚组中,第二代Stryker X3高交联聚乙烯生存优于对应传统聚乙烯。
要点
- 高交联聚乙烯全膝置换无总体生存获益,无菌翻修率显著高于传统聚乙烯。
- 常规使用高交联聚乙烯因成本增加可能缺乏合理性。
- 年龄<60岁且BMI>35 kg/m²者,第二代Stryker X3高交联聚乙烯生存优于传统聚乙烯。
核心结论
- 基于登记数据的分析显示,高交联聚乙烯在最长12年随访中无总体生存获益。
- 因成本增加,常规使用高交联聚乙烯轴承可能缺乏合理性。
- 高交联聚乙烯可能在年龄<60岁和/或BMI>35 kg/m²的高需求人群中发挥作用。
研究设计与样本
- 回顾性分析2003至2014年英格兰、威尔士和北爱尔兰国家关节登记中的初次全膝关节置换术。
- 比较钴铬-传统聚乙烯与钴铬-高交联聚乙烯轴承面,终点为全因翻修、无菌翻修和感染翻修。
- 采用每100观察年发生率、Kaplan-Meier生存估计和Cox回归风险比(校正年龄、性别、ASA分级、BMI、主刀医生级别和假体限制性)。
- 二次分析比较最常用高交联聚乙烯(Zimmer Prolong、DePuy XLK、Stryker X3)与对应传统聚乙烯在3种最常用全膝置换系统(NexGen、PFC Sigma、Triathlon)中的表现。
主要发现
- 共纳入550,658例全膝置换,其中传统聚乙烯513,744例,高交联聚乙烯36,914例。
- 未校正无菌翻修率传统聚乙烯为0.29(95%CI 0.28-0.30),高交联聚乙烯为0.38(95%CI 0.35-0.42),p<0.01。
- 传统聚乙烯10年风险比为0.4(95%CI 0.1-0.8,p=0.03)。
- 在3种最常用全膝置换系统的单独分析中,高交联聚乙烯与对应传统聚乙烯的校正翻修率无显著差异。
- 在年龄<60岁且BMI>35 kg/m²亚组中,第二代Stryker X3高交联聚乙烯生存显著优于对应传统聚乙烯,传统聚乙烯风险比为2.6(95%CI 1.2-5.9,p=0.02)。
关键数值与推荐
- 无菌翻修率:传统聚乙烯0.29(95%CI 0.28-0.30)对高交联聚乙烯0.38(95%CI 0.35-0.42),p<0.01。
- 10年风险比:传统聚乙烯0.4(95%CI 0.1-0.8),p=0.03。
- 年龄<60岁且BMI>35 kg/m²亚组中,传统聚乙烯风险比2.6(95%CI 1.2-5.9),p=0.02,比较高交联聚乙烯Stryker X3。
临床怎么用
- 全膝置换常规使用高交联聚乙烯缺乏总体生存获益证据,且成本增加。
- 对年龄<60岁且BMI>35 kg/m²的高需求患者,可考虑使用第二代Stryker X3高交联聚乙烯。
局限性
- 本研究为基于登记数据的回顾性分析,证据级别为治疗性III级。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There is evidence to support the use of highly cross-linked polyethylene (HXLPE) in patients undergoing total hip arthroplasty. However, the benefits for those undergoing total knee arthroplasty are uncertain, with conflicting reports based on previous cohort analyses. The purpose of the present study was to compare the revision rates following primary total knee arthroplasty with use of HXLPE as compared with conventional polyethylene (CPE) using data from the National Joint Registry (NJR) for England, Wales and Northern Ireland. METHODS: We performed a retrospective analysis of primary total knee arthroplasties recorded in the NJR from 2003 to 2014. Cobalt-chromium (CoCr)-CPE and CoCr-HXLPE bearing surfaces were compared using all-cause revision, aseptic revision, and septic revision as end points. Survival analyses were conducted using rates per 100 years observed, Kaplan-Meier survival estimates, and Cox regression hazard ratios (HRs) adjusted for age, sex, American Society of Anesthesiologists (ASA) classification, body mass index (BMI), lead surgeon grade, and implant constraint. Secondary analyses compared the most commonly used HXLPEs (Zimmer Prolong, DePuy XLK, and Stryker X3) against CPE for the 3 most common total knee arthroplasty systems (NexGen, PFC Sigma, and Triathlon). RESULTS: In the present study of 550,658 total knee arthroplasties, the unadjusted aseptic revision rates were significantly lower following procedures performed with CPE (n = 513,744) as compared with those performed with HXLPE total knee replacements (n = 36,914) (0.29 [95% confidence interval (CI), 0.28 to 0.30] compared to 0.38 [95% CI, 0.35 to 0.42], p < 0.01). The 10-year HR associated with CPE was 0.4 (95% CI, 0.1 to 0.8, p = 0.03). There were no significant differences between the adjusted revision rates of HXPLE compared with CPE in individual analyses of the most common total knee arthroplasty systems. However, for the subset of patients who were both <60 years of age and had a BMI of >35 kg/m, the "second-generation" Stryker X3 HXLPE demonstrated significantly better survival than its respective CPE, with CPE having an HR of 2.6 (95% CI, 1.2 to 5.9) (p = 0.02). CONCLUSIONS: Alternative bearings are marketed as having improved wear properties over traditional CoCr-CPE. This registry-based analysis demonstrated no overall survival benefit of HXLPE after a maximum duration of follow-up of 12 years. Because of their increased cost, the routine use of HXLPE bearings may not be justified. However, they may have a role in specific "higher demand" groups such as patients <60 years of age and/or those with a BMI of >35 kg/m. LEVEL OF EVIDENCE: Therapeutic Level III. See Instructions for Authors for a complete list of levels of evidence.
引用
- Partridge TCJ, Baker PN, Jameson SS, et al. Conventional Versus Highly Cross-Linked Polyethylene in Primary Total Knee Replacement: A Comparison of Revision Rates Using Data from the National Joint Registry for England, Wales, and Northern Ireland. J Bone Joint Surg Am. 2020. PMID: 31725123. doi:10.2106/JBJS.19.00031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。